SEC 13F Intelligence

Neuberger Berman Group LLC / ABT

Neuberger Berman Group LLC’s Abbott Laboratories Position

Does Neuberger Berman Group LLC own Abbott Laboratories (ABT)? Yes — 2.88M shares worth $296M (+0.22% of its 13F portfolio) as of Q1 2026, down from 4.76M shares the prior filed quarter.

Position Value
$296M
Q1 2026
Shares
2.88M
% of Portfolio
+0.22%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $61MQ4 ’18Q1 ’19: $65MQ2 ’19: $66MQ3 ’19: $65MQ4 ’19: $67MQ4 ’19Q1 ’20: $53MQ2 ’20: $57MQ3 ’20: $68MQ4 ’20: $74MQ4 ’20Q1 ’21: $95MQ2 ’21: $118MQ3 ’21: $81MQ4 ’21: $192MQ4 ’21Q1 ’22: $237MQ2 ’22: $214MQ3 ’22: $226MQ4 ’22: $69MQ4 ’22Q1 ’23: $52MQ2 ’23: $57MQ3 ’23: $80MQ4 ’23: $63MQ4 ’23Q1 ’24: $165MQ2 ’24: $144MQ3 ’24: $286MQ4 ’24: $329MQ4 ’24Q1 ’25: $575MQ2 ’25: $677MQ3 ’25: $701MQ4 ’25: $596MQ4 ’25Q1 ’26: $296Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.88M$296M+0.22%
Q4 20254.76M$596M+0.44%
Q3 20255.24M$701M+0.51%
Q2 20254.98M$677M+0.52%
Q1 20254.34M$575M+0.48%
Q4 20242.91M$329M+0.26%
Q3 20242.51M$286M+0.22%
Q2 20241.38M$144M+0.12%
Q1 20241.45M$165M+0.14%
Q4 2023574.1K$63M+0.06%
Q3 2023825.2K$80M+0.07%
Q2 2023519.7K$57M+0.05%
Q1 2023513.7K$52M+0.05%
Q4 2022626.0K$69M+0.07%
Q3 20222.34M$226M+0.24%
Q2 20221.97M$214M+0.22%
Q1 20222.00M$237M+0.20%
Q4 20211.39M$192M+0.15%
Q3 2021704.5K$81M+0.07%
Q2 20211.03M$118M+0.10%
Q1 2021800.2K$95M+0.09%
Q4 2020680.8K$74M+0.08%
Q3 2020624.9K$68M+0.08%
Q2 2020619.6K$57M+0.07%
Q1 2020674.1K$53M+0.08%
Q4 2019770.2K$67M+0.08%
Q3 2019776.3K$65M+0.08%
Q2 2019780.1K$66M+0.08%
Q1 2019808.8K$65M+0.08%
Q4 2018838.3K$61M+0.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neuberger Berman Group LLC’s full portfolio or all institutional holders of ABT.